The Effect of Singing or Playing Melodica in COPD Patients
Launched by KARADENIZ TECHNICAL UNIVERSITY · Dec 22, 2021
Trial Information
Current as of May 02, 2025
Completed
Keywords
ClinConnect Summary
The research was carried out in the chest diseases polyclinics of a hospital in Trabzon city center between September 2020 and August 2021 with 30 patients: 15 in the control group and 15 in the song/melodica group. Based on Pender's health promotion model, the control group received training and counseling for ten weeks, including face-toface training and telephone follow-up. According to Pender's health promotion model, patients in the song/melodica group were given face-to-face training once, singing/playing the melodica training twice, and counseling and follow-up over the phone twice, ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years and older,
- • Having been diagnosed with COPD by the physician based on the results of the pulmonary function test taken with spirometry according to the GOLD criteria, who are in the stable period of COPD,
- • Applying to thoracic polyclinics,
- • not bedridden,
- • Does not have vision and hearing problems that do not interfere with communication,
- • Patients who can complete the six-minute walk test,
- • Willing to sing and/or play melodica
- • Patients who agreed to participate in the study and who read and signed the informed consent form were included in the sample.
- • Exclusion Criteria:-
- • Those who do not agree to participate in the research,
- • with asthma,
- • with a diagnosis of cancer,
- • with a diagnosis of Covid-19,
- • Having unstable angina or myocardial infarction in the last 1 month,
- • Having a resting heart rate \>120/min,
- • Patients with a resting systolic blood pressure of \>180 mmHg and a diastolic blood pressure of \>100 mmHg (183) were excluded from the study.
About Karadeniz Technical University
Karadeniz Technical University is a prestigious academic institution located in Trabzon, Turkey, renowned for its commitment to advancing research and education in the fields of science and technology. As a clinical trial sponsor, the university leverages its extensive resources, expertise, and collaborative networks to conduct innovative research that enhances healthcare outcomes. With a focus on ethical standards and rigorous methodologies, Karadeniz Technical University aims to contribute valuable insights to medical science and improve patient care through well-designed clinical studies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Trabzon, , Turkey
Patients applied
Trial Officials
Elif OKUR
Principal Investigator
Karadeniz Technical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials